Expressions and clinical significances of CLDN1 and CLDN4 in human hepatocellular carcinoma
Yuan Gu(Emory University), Shuijun Zhang(Open University of China), Ji-sun Kuang(First Affiliated Hospital of Zhengzhou University), Wenlong Zhai(Zhengzhou University), Hai-feng Dong, Longshuan Zhao(First Affiliated Hospital of Zhengzhou University), Xing Dong(First Affiliated Hospital of Zhengzhou University)
Cited by 0
Related Papers
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis
|Journal of Hepatology|2022|196
Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
|Oncotarget|2015|117
NSUN2-Mediated mRNA m <b>5</b> C Modification Regulates the Progression of Hepatocellular Carcinoma
|Genomics Proteomics & Bioinformatics|2022|72